Home » Newsletters » BioWorld Asia

BioWorld Asia

July 28, 1999

View Archived Issues

Cerep, Bristol-Myers Align In Broad Deal Worth $43M

EU Debate, Confusion Continue Over Confined Use Of GMOs

Bacterium's Ability To Stimulate T Cells Could Lead To Vaccine

Ovarian Cancer Gene Therapy Enters Phase II/III in Germany

MolecularNature Focuses On Plant-Based Compounds

Canadian Start-Up Working On New Approach To Cancer

PPL Uses Gene Targeting To Produce Two Lambs

AdProTech Compound Shows Promise In Animal Models

Cortecs Gets Termination Milestone From Partner

Oxford Biomedica, Modex Enter Insulin-Delivery Deal

NiCox Starts Phase II Trial At Two Centers In France

Genset Isolates Genes Associated With Responses To Asthma Drug

Queensland Researchers Link Cancer Protein To Cholesterol

Animal Data Lead Researchers To Possible MG Therapeutic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.